NDC 45802-580 – Scopolamine Transdermal System
Scopolamine 1 mg/1 · Patch, Extended Release · Transdermal
Product NDC45802-580
Product details
- Brand name
- Scopolamine Transdermal System
- Generic name
- Scopolamine transdermal system
- Labeler
- Padagis Israel Pharmaceuticals Ltd
- Dosage form
- Patch, Extended Release
- Route
- Transdermal
- Marketing category
- ANDA · ANDA078830
- Marketed since
- June 13, 2017
- Marketing end
- June 30, 2028
- Pharmacologic class
- Anticholinergic
Active ingredients
- Scopolamine 1 mg/1
Uses, dosage, side effects and warnings for Scopolamine Transdermal System →
Package NDC codes (3)
| Package NDC | Description | Since |
|---|---|---|
| 45802-580-46 | 10 POUCH in 1 CARTON (45802-580-46) / 1 PATCH, EXTENDED RELEASE in 1 POUCH | Jun 13, 2017 |
| 45802-580-62 | 24 POUCH in 1 CARTON (45802-580-62) / 1 PATCH, EXTENDED RELEASE in 1 POUCH | Jun 13, 2017 |
| 45802-580-84 | 4 POUCH in 1 CARTON (45802-580-84) / 1 PATCH, EXTENDED RELEASE in 1 POUCH | Jun 13, 2017 |
Recalls mentioning this NDC
- D-0816-2018 May 23, 2018 · Class II
Defective delivery system
Other Scopolamine Transdermal System products
- 71335-2718 Scopolamine 1 mg/1 · Patch, Extended Release · Bryant Ranch Prepack